Hansson L
Br J Clin Pharmacol. 1987;23 Suppl 1(Suppl 1):15S-19S. doi: 10.1111/j.1365-2125.1987.tb03118.x.
Cardiovascular morbidity and mortality is higher in treated hypertensive patients than in normotensive subjects of the same age, sex and from the same populations. A possible and logical explanation for this could be that arterial pressure in treated hypertensive patients usually is significantly higher than in matched normotensive subjects. For these reasons it would appear logical to identify a therapeutic goal in the treatment of hypertension: to obtain normotensive blood pressure levels. In order to obtain this goal, combined treatment with more than one antihypertensive drug would appear to be required. Therapeutic combinations consisting of an ACE-inhibitor plus a diuretic or an ACE-inhibitor plus a calcium antagonist constitute two examples of antihypertensive drug combinations that would appear to offer potent antihypertensive efficacy and good tolerability.
接受治疗的高血压患者的心血管发病率和死亡率高于相同年龄、性别且来自相同人群的血压正常者。对此一个可能且合理的解释是,接受治疗的高血压患者的动脉压通常显著高于配对的血压正常者。基于这些原因,确定高血压治疗的目标似乎是合乎逻辑的:获得血压正常的水平。为了实现这一目标,似乎需要使用一种以上的抗高血压药物进行联合治疗。由一种血管紧张素转换酶抑制剂加一种利尿剂或一种血管紧张素转换酶抑制剂加一种钙拮抗剂组成的治疗组合是两种抗高血压药物组合的例子,它们似乎具有强大的抗高血压疗效和良好的耐受性。